IleRS Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of IleRS Antibodies targeting isoleucyl-tRNA synthetase (IleRS) for research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Isoleucyl-tRNA synthetase catalyzes the attachment of isoleucine to its corresponding tRNA, ensuring accurate protein translation. The enzyme maintains essential cellular functions and has significant implications in various diseases. Research focusing on IleRS mechanisms can advance understanding of metabolic disorders and guide therapeutic strategies. IleRS monoclonal antibodies enable precise detection and characterization of protein synthesis pathways. Studying IleRS activity patterns helps reveal cellular responses during normal and pathological conditions. Advanced research techniques incorporating IleRS analysis contribute to understanding protein synthesis regulation. Santa Cruz Biotechnology monoclonal antibodies targeting IleRS support researchers worldwide in advancing scientific knowledge of protein synthesis and disease mechanisms.